Glycoprotein antigen SIMA135 expressed in metastatic human tumor cells

Details for Australian Patent Application No. 2008201545 (hide)

International Classifications

Event Publications

24 April 2008 Complete Application Filed

1 May 2008 Application Open to Public Inspection

Published as AU-B-2008201545

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

1 December 2011 Section 223 Application Received

Novartis AG; The Scripps Research Institute An application to extend the time from 18 Feb 2011 to 18 Oct 2011 in which to pay a continuation fee has been filed . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2009

19 January 2012 Section 223 Application Allowed

Novartis AG; The Scripps Research Institute The time in which to pay a continuation fee has been extended to 18 Oct 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

2 August 2012 Application Accepted

Published as AU-B-2008201545

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.